These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 16619037)
1. Cited2 modulates TGF-beta-mediated upregulation of MMP9. Chou YT; Wang H; Chen Y; Danielpour D; Yang YC Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037 [TBL] [Abstract][Full Text] [Related]
2. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984 [TBL] [Abstract][Full Text] [Related]
3. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators. Ghosh AK; Yuan W; Mori Y; Varga J Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613 [TBL] [Abstract][Full Text] [Related]
4. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313 [TBL] [Abstract][Full Text] [Related]
5. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP. Dennler S; Pendaries V; Tacheau C; Costas MA; Mauviel A; Verrecchia F Oncogene; 2005 Mar; 24(11):1936-45. PubMed ID: 15688032 [TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional control of Cited2 by transforming growth factor beta. Regulation via Smads and Cited2 coding region. Chou YT; Yang YC J Biol Chem; 2006 Jul; 281(27):18451-62. PubMed ID: 16675452 [TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP. Cui Q; Lim SK; Zhao B; Hoffmann FM Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622 [TBL] [Abstract][Full Text] [Related]
8. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression. RodrÃguez-Pascual F; Redondo-Horcajo M; Lamas S Circ Res; 2003 Jun; 92(12):1288-95. PubMed ID: 12764024 [TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner. Pendaries V; Verrecchia F; Michel S; Mauviel A Oncogene; 2003 Nov; 22(50):8212-20. PubMed ID: 14603262 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation. Cheng PL; Chang MH; Chao CH; Lee YH Oncogene; 2004 Oct; 23(47):7821-38. PubMed ID: 15334054 [TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism. Schiller M; Verrecchia F; Mauviel A Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784 [TBL] [Abstract][Full Text] [Related]
12. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling. Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201 [TBL] [Abstract][Full Text] [Related]
13. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling. Imoto S; Sugiyama K; Sekine Y; Matsuda T FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489 [TBL] [Abstract][Full Text] [Related]
14. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction. Kuang C; Chen Y Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410 [TBL] [Abstract][Full Text] [Related]
15. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta. Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659 [TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer. Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]